Combination of chemotherapeutic agents and biological response modifiers (immunotherapy) in triple-negative/Her2( +) breast cancer, multiple myeloma, and non-small-cell lung cancer.
- Published in:
- Journal of the Egyptian National Cancer Institute, 2023, v. 34, n. 1, p. 1, doi. 10.1186/s43046-022-00159-8
- By:
- Publication type:
- Article